A detailed history of Ars Wealth Advisors Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ars Wealth Advisors Group, LLC holds 27,219 shares of PFE stock, worth $763,492. This represents 0.1% of its overall portfolio holdings.

Number of Shares
27,219
Previous 32,181 15.42%
Holding current value
$763,492
Previous $926,000 18.47%
% of portfolio
0.1%
Previous 0.14%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $128,466 - $147,520
-4,962 Reduced 15.42%
27,219 $755,000
Q4 2023

Feb 06, 2024

SELL
$26.13 - $33.94 $4.15 Million - $5.39 Million
-158,885 Reduced 83.16%
32,181 $926,000
Q3 2023

Oct 26, 2023

SELL
$32.09 - $37.51 $278,958 - $326,074
-8,693 Reduced 4.35%
191,066 $6.34 Million
Q2 2023

Jul 18, 2023

BUY
$36.12 - $41.79 $302,541 - $350,033
8,376 Added 4.38%
199,759 $7.33 Million
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $106,707 - $138,917
2,709 Added 1.44%
191,383 $7.81 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $697,934 - $911,076
-16,717 Reduced 8.14%
188,674 $9.67 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $8.99 Million - $11 Million
205,391 New
205,391 $8.99 Million
Q3 2022

Nov 08, 2022

SELL
$43.76 - $53.42 $8.7 Million - $10.6 Million
-198,699 Closed
0 $8.99 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $6.38 Million - $7.56 Million
137,041 Added 222.26%
198,699 $10.4 Million
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $40,122 - $49,717
-877 Reduced 1.4%
61,658 $3.19 Million
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $120,530 - $178,666
-2,917 Reduced 4.46%
62,535 $3.69 Million
Q3 2021

Oct 26, 2021

BUY
$39.25 - $50.42 $2.57 Million - $3.3 Million
65,452 New
65,452 $2.82 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ars Wealth Advisors Group, LLC Portfolio

Follow Ars Wealth Advisors Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ars Wealth Advisors Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ars Wealth Advisors Group, LLC with notifications on news.